IRIS
PONTREMOLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 20.518
Totale 20.518
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 20.518
Totale 20.518
Salva come PNG Salva come JPEG
Città #
Genova 16.085
Rapallo 2.135
Genoa 1.866
Vado Ligure 393
Bordighera 39
Totale 20.518
Salva come PNG Salva come JPEG
Nome #
Left ventricular dilatation and subclinical renal damage in primary hypertension 162
Early renal abnormalities as an indicator of cardiovascular risk in type 2 diabetes 160
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 150
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 148
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 147
Achievement of therapeutic targets in patients with diabetes and chronic kidney disease: Insights from the Associazione Medici Diabetologi Annals initiative 142
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 141
Characterization of the calpastatin defect in erythrocytes from patients with essential hypertension. 138
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 138
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 134
Prevalence of micro- and macroalbuminuria and their relationship with other cardiovascular risk factors in essential hypertension. 130
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 130
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 129
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 128
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 128
The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome. 127
Cardiovascular and renal effects of hyperuricaemia and gout. 126
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 126
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 126
The role of calpain in the selective increased phosphorylation of the anion-transport protein in red cell of hypertensive subjects. 125
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 124
C-reactive protein and target organ damage in untreated patients with primary hypertension. 124
Uric Acid Promotes Apoptosis in Human Proximal Tubule Cells by Oxidative Stress and the Activation of NADPH Oxidase NOX 4 124
Use of nifedipine in the treatment of hypertension. 122
Creatinine clearance and early signs of target organ damage in primary hypertension 121
Post-biopsy arteriovenous fistulas of the native kidneys diagnosed by Doppler US 120
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 119
Mild renal dysfunction and renal vascular resistance in primary hypertension 118
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 118
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 118
Highlights from International Congress 117
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 117
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 116
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 116
The calpastatin defect in hypertension is possibly due to a specific degradation by calpain. 116
Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative 116
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 115
Blood pressure levels and control in Italy: Comprehensive analysis of clinical data from 2000-2005 and 2005-2011 hypertension surveys 115
Renin–angiotensin–aldosterone system blockade in chronic kidney disease: current strategies and a look ahead 114
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 114
Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes 114
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 114
Reliability of retinal microcirculation measurements by scanning laser Doppler flowmetry in humans 113
Renal ammoniagenesis in man with chronic potassium depletion. 113
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 113
Antihyperglycemic treatment in patients with type 2 diabetes in Italy: The impact of age and kidney function 113
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 113
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 113
Hyperuricemia and renal risk 113
Overall health assessment: a renal perspective. 112
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 112
Renal and cardiac abnormalities in primary hypertension 111
Role of the fixed-dose combination lercanidipine-enalapril in renal protection. 110
Uric acid and angiotensin II additively promote inflammation and oxidative stress in human proximal tubule cells by activation of toll-like receptor 4. 110
Exploring New Options for Cardiovascular Disease Prevention May Improve Patients’ Quality of Life and Outcomes 110
Insulin activation of red blood cell Na+/H+ exchange decreases the affinity of sodium sites. 109
Blood pressure variability and multiple organ damage in primary hypertension 109
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 109
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 109
Causes and impact on survival of underuse of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in heart failure 109
Kidney disease measures are associated with the burden of coronary atherosclerosis, independently of diabetes 109
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 107
Amino acid imbalance in patients with chronic renal failure. 107
Predictors of renal complications in pediatric patients with type 1 diabetes mellitus: A prospective cohort study 107
Hypernatremia associated with severe rhabdomyolysis. 107
Hyperuricemia is associated with increased hospitalization risk and healthcare costs: Evidence from an administrative database in Italy 107
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney 106
Acute renal failure due to acute bilateral renal artery thrombosis: successful surgical revascularization after prolonged anuria. 105
Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index 105
Chronic kidney disease and albuminuria in arterial hypertension. 105
Multiple venous sampling for catecholamine assay in the diagnosis of malignant pheochromocytoma 104
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 104
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 104
Application of Temporary Filter During Percutaneous Transcatheter Embolization with Macro Coils of High-flow Massive Renal Arteriovenous Fistula 104
Diffusion-weighted MRI sequences (DW-MRI) of the kidney: normal findings, influence of hydration state and repeatibility of results 104
Vascular permeability, blood pressure, and organ damage in primary hypertension 104
microalbuminuria in essential hypetension: its relation to cardiovascular risk factors 103
RAAS Inhibition and Renal Protection 103
Association of kidney disease measures with risk of renal function worsening in patients with hypertension and type 2 diabetes 103
Kidney dysfunction and related cardiovascular risk factors among patients with type 2 diabetes 103
Nephrolithiasis by Corynebacterium urealyticum infection: Literature review and case report 103
Serum uric acid as a marker of target organ damage in primary hypertension 102
Renal ammoniagenesis in humans with chronic potassium depletion 102
Microalbuminuria in primary hypertension: a guide to optimal patient management? 102
Epidemiology of diabetic kidney disease in adult patients with type 1 diabetes in Italy: The AMD-Annals initiative 101
Five-Year Predictors of Insulin Initiation in People with Type 2 Diabetes under Real-Life Conditions 101
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 101
Trends in Prevalence, Awareness, Treatment, and Control of Blood Pressure Recorded From 2004 to 2014 During World Hypertension Day in Italy 100
SERUM URIC ACID AS A RISK FACTOR FOR CARDIOVASCULAR AND RENAL DISEASE AN OLD CONTROVERSY REVIVED. 100
Target organ damage and metabolic syndrome in non diabetic hypertensive patients 99
Global risk stratification in primary hypertension: the role of the kidney 99
Sub-clinical organ damage in hypertension and obesity 99
Normoalbuminuric kidney impairment in patients with T1DM: Insights from annals initiative 99
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes 99
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 99
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 99
Serum Uric Acid and Blood Pressure in Children at Cardiovascular Risk 99
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 98
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 98
Cardiac diastolic abnormalities and atrial natriuretic factor in essential hypertension. 97
Totale 11.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.231
article - articoli 62.809
book - libri 0
conference - conferenze 0
curatela - curatele 272
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 150
Totale 126.462
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.931 0 0 204 392 575 762 1.067 482 646 976 629 198
2020/20212.223 115 219 191 169 109 169 209 226 188 260 157 211
2021/20222.755 91 142 136 289 118 279 175 652 148 286 110 329
2022/20232.616 263 159 24 273 386 471 47 209 449 62 214 59
2023/20241.401 72 198 36 146 133 266 72 83 82 14 93 206
2024/2025449 104 344 1 0 0 0 0 0 0 0 0 0
Totale 21.024